Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2005
12/07/2005EP1602368A2 Cdc25 phosphatase inhibitors
12/07/2005EP1601695A1 Mcam inhibitors
12/07/2005EP1601694A2 Uses of il-23 agonists and antagonists; related reagents
12/07/2005EP1601686A1 Protein-binding doxorubicin peptide derivatives
12/07/2005EP1601684A2 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
12/07/2005EP1601676A2 Fused imidazoles as transforming growth factor (tgf) inhibitors
12/07/2005EP1601673A1 Novel fused heterocycles and uses thereof
12/07/2005EP1601646A2 2-substituted vitamin d analogues and their therapeutic uses
12/07/2005EP1601376A1 Use of myxoma virus for therapeutic treatment of cancer and chronic viral infection
12/07/2005EP1601372A2 Clk-peptide and slk-peptide
12/07/2005EP1601371A2 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
12/07/2005EP1601348A2 Compositions and methods with enhanced therapeutic activity
12/07/2005EP1601344A2 Enhanced delivery of sphingolipids
12/07/2005EP1601330A2 Antitumor agents comprising a targeting portion and an immune response triggering portion
12/07/2005EP1601325A2 Antisense oligonucleotides that inhibit expression of hif-1
12/07/2005EP1525198B1 Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
12/07/2005EP1496917B1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
12/07/2005EP1430073B1 Solvent extraction process
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1316558B9 Tetraphenylbacteriochlorin derivatives and compositions containing the same
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005EP1303269B1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
12/07/2005EP1301191B1 Potent immunostimulants from microalgae
12/07/2005EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
12/07/2005EP1252323B1 Virus strains for the oncolytic treatment of cancer
12/07/2005EP1247529B1 Physiologically active substance eem-s originating in mushrooms, process for producing the same and drugs
12/07/2005EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
12/07/2005EP1199306B1 Biarylurea derivatives
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005EP1169303B1 Aryl-chloroalkyl ureas
12/07/2005EP1097138B1 Pharmaceutical compositions comprising 2-quinolones
12/07/2005EP1089727B1 Liposomal formulations of busulphan
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1017394B1 Cyclin dependent kinase inhibiting purine derivatives
12/07/2005EP1014967B1 Use of zinc salts of conjugated linoleic acids to treat skin disorders
12/07/2005EP0998568B1 Mutant having uracil phosphoribosyl transferase activity
12/07/2005EP0988059B1 Human quinone reductase 2 conjugates for adept and gdept
12/07/2005EP0957917B1 Vitronectin receptor antagonists
12/07/2005EP0922105B1 Infectious papillomavirus pseudoviral particles
12/07/2005EP0794794B1 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
12/07/2005EP0738328B1 Composition containing nucleic acids, preparation and uses
12/07/2005EP0716701B1 Agent comprising serine-threonine kinase for the diagnostic and therapy of tumors
12/07/2005CN1705753A Method for diagnosing non-small cell lung cancers
12/07/2005CN1705746A Factor involved in metastasis and uses thereof
12/07/2005CN1705683A Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
12/07/2005CN1705678A Therapeutic peptides
12/07/2005CN1705677A Anti-tumour compound
12/07/2005CN1705672A New benzodioxino-isoindole derivatives, useful for treatment of cancer, are inhibitors of cell cycle
12/07/2005CN1705669A New benzo-oxazino-isoindole derivatives, useful for treating cancers, are inhibitors of the cell cycle
12/07/2005CN1705667A New fused pyrrolo-carbazole or pyrido-pyrrolo-indole derivatives (i), useful for treating cancer
12/07/2005CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
12/07/2005CN1705635A Inhibitors of histone deacetylase
12/07/2005CN1705478A Novel compounds, pharmaceutical compositions containing same, and methods of use for same
12/07/2005CN1704478A Methods for assessing patients with acute myeloid leukemia
12/07/2005CN1704417A Novel curcumenol derivatives
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1704121A Anti-angiogenic compositions and methods of use
12/07/2005CN1230538C Immunological reagent specifically interreacting with the extracellular domain of the human zeta chain
12/07/2005CN1230536C Tie-2 ligands, methods of making and uses thereof
12/07/2005CN1230535C Isolated peptides which form complexes with MHC molecule HLA-C-Clone 10 and uses thereof
12/07/2005CN1230442C GnRh antagonists being modified in positions 5 and 6
12/07/2005CN1230441C Integrin binding peptide derivatives
12/07/2005CN1230439C Cisplatinun dinuclear platinum complex for treating cancer and its therapeutic method
12/07/2005CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor
12/07/2005CN1230433C Cyclic AMP-specific phosphodiesterase inhibitors
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230418C Selective androgen receptor modulators and methods of use thereof
12/07/2005CN1230186C Natural constituents for suppressing production of blood vessel, its preparation method and use
12/07/2005CN1230169C Use of cyclopamine in the treatment of psoriasis
12/07/2005CN1230150C Slow release pharmaceutical compositions comprising lithium carbonate
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972292 Exhibit a higher degree of selectivity in killing cancer cells.
12/06/2005US6972289 dehydrodiketopiperazines such as dehydrophenylahistin used as antitumor agents; dipeptides
12/06/2005US6972288 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
12/06/2005US6972194 culturing cells in envelopes comprising acrylic amide homopolymers, for use in immunization against tumor cells and prophylaxis of diabetes; vaccines
12/06/2005US6972179 RRP sequences and knockout mice and uses thereof
12/06/2005US6972171 mixing polynucleotides with folic acid, hormones, peptides, glycoproteins, lipids or phosphatides to form nucleotides used as drugs; genetic engineering; gene expression
12/06/2005US6972128 allogeneic immunotherapy; vaccines; immortalization
12/06/2005CA2331873C Fumagillol derivatives and processes for preparing the same
12/06/2005CA2289599C Substituted heterocyclic compounds, method for preparing and compositions containing same
12/06/2005CA2272745C 2-alkyl-19-nor-vitamin d compounds
12/06/2005CA2233975C Succinimide and maleimide cytokine inhibitors
12/02/2005CA2509077A1 Water-based compositions comprising a polyethylene glycol-based solubilizing agent and a taxane useful in the treatment of coronary artery disease
12/01/2005WO2005113763A1 Inhibition of erk-phosphorylation
12/01/2005WO2005113569A1 Novel 3-triazolyl-galactoside inhibitors of galectins
12/01/2005WO2005113568A1 Novel galactoside inhibitors of galectins
12/01/2005WO2005113550A1 Aminopyrimidine derivative and medicinal use thereof
12/01/2005WO2005113546A1 Prodrugs of pyrrolylpyrimidine erk protein kinase inhibitors
12/01/2005WO2005113534A2 Cxcr1 and cxcr2 chemokine antagonists
12/01/2005WO2005113532A1 Chromene-derivatives with anti-tubulin and vascular targeting activity
12/01/2005WO2005112965A2 Botanical anti-inflammatory compositions and methods
12/01/2005WO2005112964A1 Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
12/01/2005WO2005112955A1 A composition for prevention and treatment of colon adenomas
12/01/2005WO2005112951A1 Antitumor agent, method of producing antitumor agent, medicinal composition containing antitumor agent and microorganism producing antitumor agent
12/01/2005WO2005092310A3 Chemically stable compositions of 4-hydroxy tamoxifen
12/01/2005WO2005027831A3 Modulators of p-selectin glycoprotein ligand 1
12/01/2005WO2005011730A8 Microsome vaccine
12/01/2005WO2004108715A8 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity
12/01/2005WO2003027632A3 Use of isogenic human cancer cells for high-throughput screening and drug discovery
1 ... 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 ... 2211